25/08/2021
Anemia is common among patients with chronic kidney disease (CKD), including those on dialysis. Iron deficiency is the most common reversible cause of anemia among such patients. This may be due to a true paucity of iron stores (absolute iron deficiency) or a relative (functional) deficiency that prevents the use of available iron stores. Several risk factors contribute to absolute and functional iron deficiency in CKD, including blood losses, impaired iron absorption, and chronic inflammation.
Kokino ™ is widely prescribed for iron replacement therapy in CKD patients. It is used as an iron maintenance treatment either alone or along with erythropoietin treatment.